Hepatic Resection for Extrahepatic Metastatic Disease: When Is It Reasonable?

Dominique Elias, Charles Honoré, Diane Goéré, Leonor Benhaim, David Malka, Valérie Boige, Michel Ducreux

Research output: Contribution to journalReview articlepeer-review


The presence of limited and resectable extrahepatic metastases (EHM) in addition to colorectal liver metastases (LM) is no longer a contraindication to surgery. Long-term survival (between 25 and 30 % at 5 years) is possible for highly selected patients. The site of occurrence is a key prognostic factor. Results are best for lung EHM and limited peritoneal metastases (PM), lower when EHM invade the proximal hepatic lymph nodes, and worse for other EHM. Treatment decision making is difficult when faced with an infinite number of possible combinations between the different sites of metastases, their number, and the overall tumor load. General performance status, technical contingency, and chemosensitivity are also important factors to be reckoned with. In the future, a considerable amount of data concerning these patients and new statistical tools will be required to create clear decision trees.

Original languageEnglish
Pages (from-to)78-83
Number of pages6
JournalCurrent Colorectal Cancer Reports
Issue number2
StatePublished - 1 Apr 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2015, Springer Science+Business Media New York.


  • Colorectal
  • Concomitant metastases
  • Extrahepatic disease
  • Extrahepatic metastases
  • Liver metastases
  • Lung metastases
  • Lymph node metastases
  • Nomogram
  • Peritoneal metastases


Dive into the research topics of 'Hepatic Resection for Extrahepatic Metastatic Disease: When Is It Reasonable?'. Together they form a unique fingerprint.

Cite this